ABPDU

What ABPDU does

ABPDU is a pilot-scale biomanufacturing facility established in 2009 by the U.S. Department of Energy (DOE) and operated by Lawrence Berkeley National Laboratory. The facility exists to bridge the scale-up gap between bench-scale laboratory research and commercial-scale bioprocess deployment, serving biotechnology startups, established industrial companies, and academic research institutions developing bio-based products. Its core capabilities span feedstock deconstruction, microbial fermentation, downstream purification and recovery, analytical chemistry, and techno-economic analysis, allowing partners to validate unit operations and integrated process flows at industrially relevant volumes.

The technical infrastructure at ABPDU is built around a configurable pilot plant that supports fermentation, separations, and analytical workflows, complemented by ongoing investment in digital twin development targeting 100,000+ liter bioreactor simulation. The facility participates in the Agile BioFoundry consortium, coordinates multi-laboratory collaborations for the DOE, and has expanded research scope into municipal solid waste conversion and gaseous feedstock utilization. Technical staff provide hands-on process engineering support to partners across diverse feedstocks and product targets, including pharmaceutical intermediates, specialty chemicals, food ingredients, and sustainable materials.

The operating model is government-funded rather than commercially revenue-generating. Base operations are supported through DOE appropriations as part of the national laboratory system, while industry engagement is conducted through Strategic Partnership Project (SPP) agreements and collaborative research arrangements. The facility does not sell products or licenses in a traditional commercial sense; instead, it monetizes its capabilities through cost-reimbursable projects, fee-for-service work, and joint research programs with industrial partners. Pricing and engagement terms are negotiated on a per-project basis with the goal of derisking partner scale-up rather than maximizing facility-level profitability.

Name

ABPDU

Legal name

Advanced BioProcess Development Unit (ABPDU)

Website

https://abpdu.lbl.gov

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

ABPDU is a DOE-funded pilot-scale bioprocessing facility operated by Lawrence Berkeley National Laboratory that helps biotech companies scale fermentation, purification, and analytical processes from bench to commercial relevance through collaborative research agreements.

Ownership category

akta.pro rank

Product category

Pilot-Scale Bioprocess Development Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK)

Keywords

• Bioprocess scale-up services
• Pilot-scale fermentation
• Biomass conversion technology
• Bioproduct commercialization services
• Techno-economic analysis

Headquarters

HQ city

Emeryville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. DOE Funding: ABPDU is funded by the U.S. Department of Energy's Bioenergy Technologies Office (BETO), formerly known as the Bioenergy Technologies Office. This government funding supports the facility's operations and collaborative research.
2. Industry Collaboration Projects: ABPDU generates revenue through strategic partnership projects with industry clients, where companies pay for access to facilities, expertise, and scale-up capabilities. These are contracted collaborations, such as the Strategic Partnership Project (SPP) contracts mentioned for clients like Huue.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

ABPDU is a pilot-scale bioprocessing facility that delivers bioprocess development and scale-up services to industry partners, enabling early-stage advanced biofuels, biomaterials, biochemicals, and pharmaceutical ingredient technologies to scale from laboratory prototype to commercial relevance. The facility provides end-to-end capabilities spanning biomass deconstruction and catalysis, fermentation, downstream purification and recovery, analytical chemistry, materials handling, and techno-economic analysis. Industry partners engage through project-based collaborations at the Emeryville, CA facility under Strategic Partnership Project agreements with Lawrence Berkeley National Laboratory.

Product overview

The Advanced BioProcess Development Unit (ABPDU) is a pilot-scale bioprocessing facility at Lawrence Berkeley National Laboratory, not a traditional product company. It offers a comprehensive suite of bioprocess development and scale-up services including deconstruction & catalysis, fermentation, purification & recovery, and analytical chemistry capabilities. The facility provides process development, feedstock flexibility, and technical validation services to help biotech companies scale innovative biotechnologies from lab to commercial relevance. Equipment includes pilot-scale bioreactors (50L-300L), high-throughput systems, and comprehensive analytical instrumentation. ABPDU has collaborated with over 90 industry partners to accelerate bio-based product commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioprocess Development and Scale-Up Services Comprehensive bioprocessing services enabling early-stage advanced biofuels, biomaterials, biochemicals, and pharmaceutical ingredient technologies to successfully scale from laboratory prototype to commercial relevance, serving biotech startups, established companies, and research institutions.
• Diversity of Bioproducts and Bioprocesses Services Service for optimizing, scaling up, and demonstrating bioproduct processes across diverse microbial hosts and novel or drop-in advanced bioproduct molecules, for biotech companies developing innovative bioproducts.
• Feedstock Flexibility Services Service providing expertise in processing diverse feedstocks including lignocellulosic biomass, municipal solid waste, gaseous feedstocks, and next-generation biomass-based inputs, enabling partners to test and validate processes across a wide range of raw materials.
• Process Development and Optimization Service focused on mitigating partner risk during scale-up and accelerating technology readiness levels, using flexible, customizable equipment and experienced team to quickly prototype and adjust bio-processes for biotech and biomanufacturing partners.
• Technical and Strategic Development Services Service providing impartial third-party validation of commercial feasibility for bio-concepts, delivering stakeholders and investors confidence in technology readiness and commercialization potential of novel bio-based products.
• Scale-Up Integration and Product Prototyping Service integrating pilot processes using capital project and industry best practices to move advanced bioproducts from bench scale to commercial manufacturing, including downstream recovery prototyping and pilot-scale demonstration.
• Funding and Grant Proposals Support

Quantifiable outcome

• Over 90 industry partners collaborated with since establishment
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• AntheiacoreStrategic or Co-development Partner · 1 January 2019ABPDU has partnered with Antheia since 2019 to scale pharmaceutical ingredient production. The collaboration focused on fermentation and downstream processing for thebaine, a key ingredient in essential medicines including Narcan. ABPDU's pilot runs generated representative material for customer sampling and regulatory testing, validated process performance at larger scale, and provided data for confident move to full scale manufacturing at 100kL+.
• Lawrence Berkeley National LaboratorycoreStrategic or Co-development PartnerABPDU is part of Lawrence Berkeley National Laboratory (Berkeley Lab) and operates under its auspices. Berkeley Lab is a U.S. Department of Energy national laboratory.
• U.S. Department of Energy - Bioenergy Technologies Office (BETO)coreStrategic or Co-development PartnerABPDU is funded by DOE's Bioenergy Technologies Office (BETO), formerly known as the Bioenergy Technologies Office. The office funds and supports ABPDU's operations and collaborative research in bioeconomy advancement.
• Joint BioEnergy Institute (JBEI)majorStrategic or Co-development PartnerJBEI is a DOE Bioenergy Research Center that ABPDU collaborates with extensively. Joint projects include biomass conversion research, plastic depolymerization, and shared research facilities.
• Oobli (formerly Joywell Foods)majorStrategic or Co-development PartnerABPDU collaborated with Oobli to scale up production of sweet proteins through fermentation. The teams completed three successful piloting campaigns and optimized the process for further scale-up and commercialization readiness.
• HuuemajorStrategic or Co-development PartnerABPDU partnered with Huue to produce microbially-produced indigo dye at industrial scale. Within 14 weeks, ABPDU scaled the process to 300 liters and generated enough product to dye cotton yarn for IndieBio's Demo Day.
• Ruby BiomajorStrategic or Co-development PartnerRuby Bio partnered with ABPDU in 2022 for initial scale-up of their naturally derived biosurfactants. Production was successfully scaled from 10L to 300L, setting the stage for commercialization.
• CheckerspotmajorStrategic or Co-development PartnerABPDU helped Checkerspot scale up a process to use algae oils to create polymers for recreational equipment like skis. The collaboration led to WNDR Alpine's ski launch in 2019.
• Agile BioFoundrymajorStrategic or Co-development PartnerABPDU manages outside collaborations for the Agile BioFoundry, a DOE-funded consortium focused on advancing biotechnology through data-driven approaches.
• Caspr BiotechmajorStrategic or Co-development PartnerABPDU helped scale Caspr Biotech's CRISPR Cas-12 enzyme production for COVID-19 testing kits. Fermentation was scaled from tiny batches to 10-liter bioreactors.
• Swiftscale BiologicsmajorStrategic or Co-development PartnerABPDU collaborated with Swiftscale to scale up their antibody development platform 1,000-fold from 250mL to 300L for potential clinical trials.
• Almond Board of CaliforniaminorStrategic or Co-development PartnerABPDU conducted techno-economic analysis for the Almond Board of California on repurposing almond shells as plastic reinforcing agents through torrefaction.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Argonne National Laboratory: DOE national laboratory with biotechnology and bioenergy research programs, offering analytical and process capabilities to industry partners. Comparable as a federally funded R&D peer in the same mission space as ABPDU under the DOE complex.
• Oak Ridge National Laboratory (ORNL): DOE national laboratory with bioenergy and bioprocessing pilot capabilities, including the BioEnergy Science Center. Directly comparable as a federally funded peer advancing pilot-scale bioeconomy technologies.
• Pacific Northwest National Laboratory (PNNL): DOE national laboratory with bioprocessing and renewable fuels research programs serving industry and government clients. Comparable as a federally funded R&D peer with similar scale-up infrastructure and DOE mandate.
• Catalent (Novo Holdings): Global CDMO offering development and manufacturing services for biologics and small molecules, including fermentation and process scale-up. Comparable as a larger, established contract development peer addressing overlapping biotech scale-up needs.
• National Renewable Energy Laboratory (NREL): DOE national laboratory with analogous mission in bioenergy and bioprocess R&D, operating pilot-scale facilities for renewable fuels and chemicals. Directly comparable as a federally funded peer providing process development and scale-up infrastructure for the bioeconomy.

Direct peers

• Codexis: Public enzyme engineering and biocatalysis company offering process development and scale-up services for pharma and industrial biotech customers. Comparable as a contract bioprocess development and scale-up peer with similar customer base in pharma and chemicals.
• Amyris: Synthetic biology company that develops and scaled fermentation-derived ingredients for cosmetics, flavors, and fuels, operating pilot through commercial bioprocess infrastructure. Comparable as a fermentation scale-up peer serving similar industrial biotech customers in specialty chemicals.
• Ginkgo Bioworks: Public synthetic biology company operating the "Foundry" platform for organism engineering and pilot-scale bioprocess development. Directly comparable as a scale-up platform enabling biotech startups to move from lab to commercial production across diverse product categories.
• LanzaTech: Private carbon recycling company that ferments gaseous feedstocks (CO, CO2) into fuels and chemicals at pilot and commercial scale. Comparable as a gas-fermentation bioprocess development peer that has worked with ABPDU's ecosystem on DOE-funded feedstock research.

Emerging players

• Cysbio: Synthetic biology company developing fermentation-based bioprocesses for commodity and specialty chemicals. Comparable as an emerging player in the same microbial bioprocess development space, though focused more on in-house product development than serving external clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/abpdu
• YouTubeyoutube.com/channel/UCm33SDMpniXddgBa0OEBJnA?view_as=subscriber
• LinkedInlinkedin.com/company/abpdu

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABPDU